Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.
about
My approach to the treatment of sclerodermaChronic intestinal pseudo-obstructionIntestinal manometry: who needs it?Review article: the assessment and management of chronic severe gastrointestinal dysmotility in adultsChronic intestinal pseudo-obstructionDiagnosis and management of adult patients with chronic intestinal pseudoobstructionRoles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones.Pediatric small intestine bacterial overgrowth in low-income countries.Effect of octreotide on gastric and small bowel motility in patients with gastroparesis.Gas and Bloating.Two Cases of Chronic Idiopathic Intestinal Pseudo-obstruction with Different Clinical FeaturesAntimyenteric neuronal antibodies in sclerodermaAmelioration of intestinal dysmotility and stasis by octreotide early after small-bowel autotransplantation in dogs.Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disorders.Differential regional effects of octreotide on human gastrointestinal motor functionEffect of octreotide on fasting gall bladder emptying, antroduodenal motility, and motilin release in acromegaly.Relationship between dietary-induced changes in intestinal commensal microflora and duodenojejunal myoelectric activity monitored by radiotelemetry in the rat in vivo.Effect of octreotide on enteric motor neurons in experimental acute necrotizing pancreatitisCurrent treatment options in systemic Sclerosis (Scleroderma).Gastrointestinal manifestations of systemic sclerosis.Preventive effect of Lactobacillus fermentum Lee on activated carbon-induced constipation in miceSmall intestinal bacterial overgrowth in systemic sclerosis.Preventive effect of Dendrobium candidum Wall. ex Lindl. on activated carbon-induced constipation in mice.Small intestinal bacterial overgrowth: a comprehensive reviewGas and the microbiome.Chronic intestinal pseudo-obstruction in systemic lupus erythematosus.Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans.Management of gastrointestinal involvement in scleroderma.Current management of the gastrointestinal complications of systemic sclerosis.Parenteral nutrition-associated liver disease in adult and pediatric patients.Severe delayed complication after percutaneous endoscopic colostomy for chronic intestinal pseudo-obstruction: a case report and review of the literaturePreventive effect of resistant starch on activated carbon-induced constipation in miceChronic intestinal pseudo-obstruction in adult patients: multidetector row helical CT features.Review article: molecular, pathological and therapeutic features of human enteric neuropathies.Successful palliation of diarrhea owing to malignant duodenocolic fistula by octreotide.Review article: small intestinal bacterial overgrowth--prevalence, clinical features, current and developing diagnostic tests, and treatment.Distinguishing between limited systemic scleroderma-associated pseudo-obstruction and peritoneal disseminationRedefining the functional roles of the gastrointestinal migrating motor complex and motilin in small bacterial overgrowth and hunger signaling.Chronic intestinal pseudo-obstruction in children and adults: diagnosis and therapeutic options.Small Bowel Motility.
P2860
Q24618843-F6DCA777-E546-40AE-B0DE-10000A078AF5Q24647826-C42F14CF-BEF1-4282-BCC3-FFCAD30BFD86Q26782840-F5CE5CB0-1687-4139-9223-0352479CCCB4Q27030666-E11FE7FB-9935-4D0A-87AA-9FACE8AB40CAQ28289526-B9F3D7C9-8796-479A-BBF9-5C00DB403758Q28293980-2C59043E-ADC0-4827-AFE4-CB915F369245Q28378941-254FCA48-775D-42DF-B330-A865B4B7E35CQ30301148-5A6F50EA-F606-4104-835A-E262B0A5EFE9Q30472416-A1299EDB-F351-40D9-9E32-AE1B901C3595Q33470091-BB1E593B-09AE-4D81-A43B-07554AAEE40FQ33890460-E121529F-CB53-4284-B19B-02F9EB25A2D5Q34229391-60B42D8D-2A82-4FE1-996E-E873699FB6F4Q34247961-073C6FD1-E6FB-4CBA-9B97-009886429A13Q34379963-6B60DD10-5B8A-4B60-82FA-5AE626837CDEQ34408321-82E5C02B-C19F-40A6-9FD1-24EC66D022CEQ34408333-D2CD9FE4-6270-4523-BA96-CF340A081302Q34464551-C48C09A5-5B24-4F68-90A9-60BCF3BB23E8Q34540431-D177D09A-A059-4666-81B0-BC361C99A76BQ34567929-CED40335-03F8-4131-8A31-4E93D9619A5AQ34583730-BAB527C8-766C-4BDA-BAE5-E9B2B1C8F75FQ34585343-4132193F-7362-4B68-9C04-F11D207050EAQ34611011-40C94ED0-46BE-43E9-8079-784B1DFEBEB0Q34795839-8D8DFF7E-6A01-42F2-8224-259FA6EB10BCQ34996846-CACADD2A-F927-4A0A-B47B-002CFB38FBC3Q35024458-F750C989-35E7-4CA4-9E8D-CCC330A7018FQ35351498-991EC876-E6F8-4C05-B567-AB8C27EA0E00Q35596092-B23E5E53-A1D6-48FC-B7CA-D3D1EB2888C6Q35624333-B6043ABF-24D9-49FE-A30C-31B2D3864D95Q36068493-78384A79-FAD1-4E82-850B-ED68B0196D28Q36506091-468EDBB0-E649-4153-BF97-829038377F07Q36804335-0343B9C6-2227-4538-9E54-945C50CAB3FBQ37075595-32DB77FC-B8C7-4B22-B569-D94472394A77Q37115486-4CC77A20-D305-4B63-B106-5EF3557CBE37Q37137991-AF3C710F-BA56-4E7E-B8C6-97AC0FAB5E05Q37472370-690180FA-6114-4DEB-A0BD-0047665D4A65Q38129946-27EBD159-8621-4DAD-911E-201EAA441A4DQ38326760-F84AE053-20D0-49A2-AD5F-0E4C559EDB97Q38667541-F2286482-04CB-46EA-9DE0-521C28E67157Q38967384-77E11DEB-742D-4EE3-8DAB-1F1DBA7152ECQ39254007-FDDAF13B-7D24-4727-A5C8-5284D30AFFA9
P2860
Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.
@en
Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.
@nl
type
label
Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.
@en
Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.
@nl
prefLabel
Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.
@en
Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.
@nl
P2093
P1476
Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.
@en
P2093
P304
P356
10.1056/NEJM199111213252102
P407
P577
1991-11-01T00:00:00Z